WHO Sounds Alert Over Acute Shortage of Obesity Medications
Less than one in 10 people eligible to benefit from obesity jabs like Wegovy can access them, states the World Health Organization as it publishes its inaugural recommendations on the therapies.
Considering in excess of 1,000,000,000 individuals worldwide currently obese, it is urging broader and more equitable access to these injectable treatments.
Based on projections, more than two billion are projected to be living with obesity by 2030 if no action is taken.
"The new guidelines recognises that obesity is a chronic disease that can be addressed with comprehensive and lifelong support," stated WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and logistical bottlenecks are significant barriers to universal availability to the treatments that can help people shift significant weight, notes the organization.
GLP-1 Therapy Shortage
Even in the present best projected scenario, the manufacturing of these medications might only reach approximately 100 million people – less than 10% of the global need, according to the health organization.
The recommendation urges countries and companies to widen access, by approaches such as patent sharing.
A patent on a key compound – the primary component of a leading brand – is set to lapse in a number of countries in 2026.
The Way Weight-Loss Drugs Work
These medications mimick a natural hormone to slow digestion, suppress the appetite and boost feelings of fullness so individuals consume fewer calories.
Individuals usually begin shedding pounds after several weeks of commencing the weekly injections.
Studies points to patients may put most of the weight back on a year later of discontinuing the treatment, because their usual food cravings return.
To be above a healthy weight elevates your likelihood for developing health problems, such as diabetes, cardiovascular issues, brain attack, and specific malignancies.
Excess weight impacts individuals in all nations and was responsible for millions of fatalities worldwide in 2024, according to the WHO.
